Lee Ann Prebil

Lee Ann Prebil

Auto-generated profile, based on publicly available information

Lee Ann Prebil

Marin County Department of Health and Human Services, Division of Public Health , Marin, California , USA

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 1999 in Quality of Life Research
Verified
Journal Article
Closed access
PDF file
DLDeborah P. Lubeck
Deborah P. Lubeck
LPLee Ann Prebil
Lee Ann Prebil
PPPatti Peeples
Patti Peeples
JBJeanette S. Brown
Jeanette S. Brown

1 October 1999 in Drug Information Journal
Verified
Journal Article
Closed access
SMSusan D. Mathias
Susan D. Mathias
LPLee Ann Prebil
Lee Ann Prebil
CPCaryn G. Putterman
Caryn G. Putterman
JCJoseph J. Chmiel
Joseph J. Chmiel
RTRichard C. Throm
Richard C. Throm
ACAnthony J. Comerota
Anthony J. Comerota

30 April 2010 in BMC Public Health
Verified
Journal Article
Open access
PDF file
RERochelle R Ereman
Rochelle R Ereman
LPLee Ann Prebil
Lee Ann Prebil
MMMary Mockus
Mary Mockus
KKKathy Koblick
Kathy Koblick
FOFern Orenstein
Fern Orenstein
CCChristina A Clarke
Christina A Clarke
Recent declines in invasive breast cancer have been reported in the US, with many studies linking these declines to reductions in the use of combination estrogen/progestin hormone therapy (EPHT). We evaluated the changing use of postmenopausal hormone therapy, mammography screening rates, and the decline in breast cancer incidence specifically for Marin County, California, a population with historically elevated breast cancer incidence rates. The Marin Women's Study (MWS) is a community-based, prospective cohort study launched in 2006 to monitor changes in breast cancer, breast density, and personal and biologic risk factors among women living in Marin County. The MWS enrolled 1,833 women following routine screening mammography between October 2006 and July 2007. Participants completed a self-administered questionnaire that included items regarding historical hormone therapy regimen (estrogen only, progesterone only, EPHT), age of first and last use, total years of use, and reason(s) for stopping, as well as information regarding complementary hormone use. Questionnaire items were analyzed for 1,083 non-Hispanic white participants ages 50 and over. Breast cancer incidence rates were assessed overall and by tumor histology and estrogen receptor (ER) status for the years 1990-2007 using data from the Northern California Surveillance, Epidemiology and End Results (SEER) cancer registry. Prevalence of EPHT use among non-Hispanic white women ages 50 and over declined sharply from 21.2% in 1998 to 6.7% by 2006-07. Estrogen only use declined from 26.9% in 1998 to 22.4% by 2006-07. Invasive breast cancer incidence rates declined 33.4% between 2001 and 2004, with drops most pronounced for ER+ cancers. These rate reductions corresponded to declines of about 50 cases per year, consistent with population attributable fraction estimates for EPHT-related breast cancer. Self-reported screening mammography rates did not change during this period. Use of alternative or complementary agents did not differ significantly between ever and never hormone users. Of women who reported stopping EPHT in the past 5 years, 60% cited "health risks" or "news reports" as their primary reasons for quitting. A dramatic reduction in EPHT use was followed temporally by a significant reduction in invasive and ER+ breast cancer rates among women living in Marin County, California.

25 March 2009 in BMC Women's Health
Verified
Journal Article
Open access
SLSuzanne Lea
Suzanne Lea
NGNancy P Gordon
Nancy P Gordon
LPLee Ann Prebil
Lee Ann Prebil
RERochelle Ereman
Rochelle Ereman
CUConnie S Uratsu
Connie S Uratsu
MPMark Powell
Mark Powell
The Northern California county of Marin (MC) has historically had high breast cancer incidence rates. Because of MC's high socioeconomic status (SES) and racial homogeneity (non-Hispanic White), it has been difficult to assess whether these elevated rates result from a combination of established risk factors or other behavioral or environmental factors. This survey was designed to compare potential breast cancer risks and incidence rates for a sample of middle-aged MC women with those of a demographically similar population. A random sample of 1500 middle-aged female members of a large Northern California health plan, half from Marin County (MC) and half from a comparison area in East/Central Contra Costa County (ECCC), were mailed a survey covering family history, reproductive history, use of oral contraceptives (OC) and hormone replacement therapy (HRT), behavioral health risks, recency of breast screening, and demographic characteristics. Weighted data were used to compare prevalence of individual breast cancer risk factors and Gail scores. Age-adjusted cumulative breast cancer incidence rates (2000–2004) were also calculated for female health plan members aged 40–64 residing in the two geographic areas. Survey response was 57.1% (n = 427) and 47.9% (n = 359) for MC and ECCC samples, respectively. Women in the two areas were similar in SES, race, obesity, exercise frequency, current smoking, ever use of OCs and HRT, age at onset of menarche, high mammography rates, family history of breast cancer, and Gail scores. However, MC women were significantly more likely than ECCC women to be former smokers (43.6% vs. 31.2%), have Ashkenazi Jewish heritage (12.8% vs. 7.1%), have no live births before age 30 (52.7% vs. 40.8%), and be nulliparous (29.2% vs. 15.4%), and less likely to never or rarely consume alcohol (34.4% vs. 41.9%). MC and ECCC women had comparable 2000–2004 invasive breast cancer incidence rates. The effects of reproductive risks factors, Ashkenazi Jewish heritage, smoking history, and alcohol consumption with regard to breast cancer risk in Marin County should be further evaluated. When possible, future comparisons of breast cancer incidence rates between regions should adjust for differences in income and education in addition to age and race/ethnicity, preferably by using a sociodemographically similar comparison group.

15 November 2000
Verified
Journal Article
Closed access
SMS D Mathias
S D Mathias
LPL A Prebil
L A Prebil
WBW L Boyko
W L Boyko
JFJ Fastenau
J Fastenau

1 February 2023 in Open Forum Infectious Diseases
Verified
Journal Article
Open access
PDF file
DMDavid A Miller
David A Miller
LDLael Duncan
Lael Duncan
LTLindsey Termini
Lindsey Termini
LPLee Ann Prebil
Lee Ann Prebil
DWDavid Witt
David Witt
SMStephen A McCurdy
Stephen A McCurdy
Mitigation of coronavirus disease 2019 (COVID-19) outbreaks in long-term care facilities (LTCFs) is facilitated by rapid identification and isolation of infectious individuals to interrupt viral transmission. Immunochromatographic (IC) tests, or rapid antigen tests, have high sensitivity and specificity during the contagious period for COVID-19. Mathematical modeling predicts frequent IC surveillance will be more efficient than polymerase chain reaction (PCR)-based strategies, especially during community surges when reporting of PCR results can be delayed. However, there are few published field studies evaluating IC testing strategies in this long-term care setting. In fall and winter of 2020, the Marin Health and Human Services Department implemented thrice-weekly IC mass testing by nonlaboratory workers in outbreaks that occurred in 2 LTCFs, in addition to then-standard semiweekly PCR testing. The IC test performance was characterized using same-day PCR specimens as reference standard. Cumulative incidence and duration of transmission for the 2 IC intervention facility outbreaks were compared with 6 reference LTCFs that used weekly to semiweekly PCR alone during an outbreak response. Of 123 same-day test pairs, IC test sensitivity and specificity were 75% (95% confidence interval [CI], 48%–93%) and 100% (95% CI, 97%–100%), respectively. The median duration of outbreak transmission was 19.5 days in the 2 intervention sites and 28 days in the reference facilities (P = .40). Cumulative incidence for the outbreaks among LTCF residents was 41% in the intervention facilities versus 52% in the reference facilities (P = .04, Fisher 2-sided exact). Thrice-weekly mass IC testing as used by nonlaboratory personnel can be highly practical and effective for COVID-19 outbreak mitigation in the LTCF setting.